Immunosuppression reduction when administering a booster dose of the BNT162b2 mRNA SARS-CoV-2 vaccine in kidney transplant recipients without adequate humoral response following two vaccine doses: protocol for a randomised controlled trial (BECAME study)

Publication | Open Access

DOI Full Paper Access

Citations

References

2021

Year

Dafna Yahav, Benaya Rozen‐Zvi, Tiki Mashraki, Alaa Atamna, Haim Ben‐Zvi, Erez Bar‐Haim, Ruth Rahamimov

BMJ Open

Abstract

References